NCT03425279 2025-09-23CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With SarcomaBioAtla, Inc.Phase 1/2 Completed245 enrolled
NCT01962103 2019-12-27Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid TumorsCelgenePhase 1/2 Completed107 enrolled 42 charts
NCT01154452 2018-08-15Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaNational Cancer Institute (NCI)Phase 1/2 Completed78 enrolled 11 charts
NCT00122473 2011-07-29Imatinib in Dermatofibrosarcoma Protuberans (DFSP)Dermatologic Cooperative Oncology GroupPhase 1/2 Completed30 enrolled